Try it
Pharmacology · Antimicrobials: rifamycins and protease inhibitors
Sample itemA man with HIV on a protease-inhibitor-based regimen develops pulmonary tuberculosis. Which rifamycin is a weaker inducer of CYP3A4 and is preferred over rifampicin in this setting?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
C. Rifabutin
Rifampicin strongly induces CYP3A4 and lowers protease inhibitor levels to subtherapeutic concentrations. Rifabutin is a much weaker inducer and is used with dose adjustment instead. Rifapentine is a strong inducer, and rifaximin is not absorbed and not used for tuberculosis.
Option by option
A. Rifampicin at a higher dose
A higher rifampicin dose would induce still more and lower protease inhibitor levels further.
B. Rifaximin
Rifaximin is poorly absorbed and is not used for tuberculosis.
C. Rifabutin (correct)
Correct. It is a weak CYP3A4 inducer and can be used with protease inhibitors.
D. Rifapentine
Rifapentine is a strong inducer, similar to rifampicin.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?